|
T1119 |
Rasagiline
|
AGN1135,TVP1012 |
BCL
,
MAO
,
Monoamine Oxidase
|
|
Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease. |
|
T6962 |
Rasagiline Mesylate
|
TVP1012,AGN1135,Azilect |
Apoptosis
,
MAO
,
Autophagy
,
Monoamine Oxidase
|
|
Rasagiline Mesylate (AGN1135) is a novel MAO-B inhibitor, which can treat idiopathic Parkinson's disease. |
|
T36903 |
Rasagiline-13C3 (mesylate)
|
Rasagiline-13C3 (mesylate) |
|
|
Rasagiline-13C3is intended for use as an internal standard for the quantification of rasagiline by GC- or LC-MS. Rasagiline is an inhibitor of monoamine oxidase B (MAO-B; IC50= 4.43 nM for the rat brain enzyme).1It is se... |
|
T71910 |
Racemic rasagiline
|
|
|
|
Racemic rasagiline, also known as AGN-1135, is a Monoamine Oxidase type-B inhibitor (MAOI). However, application of this drug can lead to fatal hypertensive crisis in patients who consume tyramine-rich foods. TVP-102... |
|
T13252 |
(S)-Rasagiline
|
TVP1022,S-PAI |
Others
|
|
(S)-Rasagiline is rasagiline S-isomer, and is an agent of anti-Parkinson. |
|
T12693 |
Rasagiline 13C3 mesylate racemic
|
TVP1012 13C3 racemic,AGN1135 13C3 racemic |
Others
|
|
Rasagiline 13C3 mesylate racemic is the deuterium labeled Rasagiline, which is an irreversible monoamine oxidase inhibitor. |
|
T13252L |
(S)-Rasagiline mesylate
|
TVP1022 (mesylate),S-PAI mesylate |
Others
|
|
(S)-Rasagiline mesylate is rasagiline S-isomer, and is an agent of anti-Parkinson. |
|
T73530 |
2-PAT
|
|
|
|
2-PAT, analogous to Rasagiline and Selegiline, functions as a reversible MAO-A inhibitor, exhibiting an IC50 of 0.721 µM, and acts as an inactivator of MAO-B with an IC50 value of 14.6 µM. This compound shows promise for... |
